^ 9.09.19.2Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature. 2002, 419 (6905): 395–9 [2024-02-05]. Bibcode:2002Natur.419..395C. PMID 12353035. S2CID 4359174. doi:10.1038/nature01063. (原始内容存档于2023-03-27).
^Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA, Shore GC. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J. Cell Biol. October 1997, 139 (2): 327–38. PMC 2139787. PMID 9334338. doi:10.1083/jcb.139.2.327.
^ 11.011.111.211.311.411.5Gajate C, Mollinedo F. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J. Biol. Chem. March 2005, 280 (12): 11641–7. PMID 15659383. doi:10.1074/jbc.M411781200.
^ 12.012.112.212.312.412.512.612.7Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. April 2002, 277 (16): 13430–7. PMID 11832478. doi:10.1074/jbc.M108029200.
^Poulaki V, Mitsiades N, Romero ME, Tsokos M. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Cancer Res. June 2001, 61 (12): 4864–72. PMID 11406564.
^ 14.014.114.214.314.4Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes (PDF). Cell. July 2003, 114 (2): 181–90 [2024-02-05]. PMID 12887920. S2CID 17145731. doi:10.1016/s0092-8674(03)00521-x. (原始内容存档 (PDF)于2023-01-27).
^ 15.015.1Shu HB, Halpin DR, Goeddel DV. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity. June 1997, 6 (6): 751–63. PMID 9208847. doi:10.1016/s1074-7613(00)80450-1.
^Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. August 1997, 272 (32): 19641–4. PMID 9289491. doi:10.1074/jbc.272.32.19641.
^ 17.017.1Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, Wang Y, Fernandes-Alnemri T, Croce CM, Litwack G, Tomaselli KJ, Armstrong RC, Alnemri ES. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. July 1997, 272 (30): 18542–5. PMID 9228018. doi:10.1074/jbc.272.30.18542.
^Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW, Briand C, Grütter MG. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. November 2002, 277 (47): 45162–71. PMID 12215447. doi:10.1074/jbc.M206882200.
^Han DK, Chaudhary PM, Wright ME, Friedman C, Trask BJ, Riedel RT, Baskin DG, Schwartz SM, Hood L. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc. Natl. Acad. Sci. U.S.A. October 1997, 94 (21): 11333–8. Bibcode:1997PNAS...9411333H. PMC 23459. PMID 9326610. doi:10.1073/pnas.94.21.11333.
^Roth W, Stenner-Liewen F, Pawlowski K, Godzik A, Reed JC. Identification and characterization of DEDD2, a death effector domain-containing protein. J. Biol. Chem. March 2002, 277 (9): 7501–8. PMID 11741985. doi:10.1074/jbc.M110749200.
^ 21.021.121.221.321.421.5Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. U.S.A. December 1996, 93 (25): 14486–91. Bibcode:1996PNAS...9314486S. PMC 26159. PMID 8962078. doi:10.1073/pnas.93.25.14486.
^Cowling V, Downward J. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ. October 2002, 9 (10): 1046–56. PMID 12232792. doi:10.1038/sj.cdd.4401065.
^Zhan Y, Hegde R, Srinivasula SM, Fernandes-Alnemri T, Alnemri ES. Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC. Cell Death Differ. April 2002, 9 (4): 439–47. PMID 11965497. doi:10.1038/sj.cdd.4401038.
^Alcivar A, Hu S, Tang J, Yang X. DEDD and DEDD2 associate with caspase-8/10 and signal cell death. Oncogene. January 2003, 22 (2): 291–7. PMID 12527898. doi:10.1038/sj.onc.1206099.
^Stegh AH, Schickling O, Ehret A, Scaffidi C, Peterhänsel C, Hofmann TG, Grummt I, Krammer PH, Peter ME. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J. October 1998, 17 (20): 5974–86. PMC 1170924. PMID 9774341. doi:10.1093/emboj/17.20.5974.
^ 26.026.1Oshima S, Turer EE, Callahan JA, Chai S, Advincula R, Barrera J, Shifrin N, Lee B, Benedict Yen TS, Yen B, Woo T, Malynn BA, Ma A. ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature. February 2009, 457 (7231): 906–9. Bibcode:2009Natur.457..906O. PMC 2642523. PMID 19060883. doi:10.1038/nature07575.
^Henshall DC, Araki T, Schindler CK, Shinoda S, Lan JQ, Simon RP. Expression of death-associated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures. J. Neurochem. September 2003, 86 (5): 1260–70. PMID 12911633. S2CID 21971958. doi:10.1046/j.1471-4159.2003.01934.x.
^Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. June 1996, 85 (6): 803–15. PMID 8681376. S2CID 7415784. doi:10.1016/s0092-8674(00)81265-9.
^Thomas LR, Stillman DJ, Thorburn A. Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen. J. Biol. Chem. September 2002, 277 (37): 34343–8. PMID 12107169. doi:10.1074/jbc.M204169200.
^ 30.030.1MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. October 1997, 272 (41): 25417–20. PMID 9325248. doi:10.1074/jbc.272.41.25417.
^Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst CA, Leavitt BR, Metzler M, Hackam AS, Tam J, Vaillancourt JP, Houtzager V, Rasper DM, Roy S, Hayden MR, Nicholson DW. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell Biol. February 2002, 4 (2): 95–105. PMID 11788820. S2CID 10439592. doi:10.1038/ncb735.
^Koseki T, Inohara N, Chen S, Núñez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. U.S.A. April 1998, 95 (9): 5156–60. Bibcode:1998PNAS...95.5156K. PMC 20230. PMID 9560245. doi:10.1073/pnas.95.9.5156.
^Kitsberg D, Formstecher E, Fauquet M, Kubes M, Cordier J, Canton B, Pan G, Rolli M, Glowinski J, Chneiweiss H. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J. Neurosci. October 1999, 19 (19): 8244–51. PMC 6783010. PMID 10493725. doi:10.1523/JNEUROSCI.19-19-08244.1999.
^Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalò P, Oriente F, Miele C, Caruso M, Formisano P, Beguinot F. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene. August 1999, 18 (31): 4409–15. PMID 10442631. S2CID 20510429. doi:10.1038/sj.onc.1202831.
^Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L. Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene. September 2000, 19 (39): 4451–60. PMID 11002417. doi:10.1038/sj.onc.1203812.
^Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell. June 2008, 30 (6): 689–700. PMID 18570872. doi:10.1016/j.molcel.2008.05.014.
^Leo E, Deveraux QL, Buchholtz C, Welsh K, Matsuzawa S, Stennicke HR, Salvesen GS, Reed JC. TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis. J. Biol. Chem. March 2001, 276 (11): 8087–93. PMID 11098060. doi:10.1074/jbc.M009450200.
拓展阅读
Jia SH, Parodo J, Kapus A, Rotstein OD, Marshall JC. Dynamic Regulation of Neutrophil Survival through Tyrosine Phosphorylation or Dephosphorylation of Caspase-8. Journal of Biological Chemistry. 2008, 283 (9): 5402–5413. PMID 18086677. doi:10.1074/jbc.M706462200.
Cohen GM. Caspases: the executioners of apoptosis. Biochem. J. 1997, 326 (Pt 1): 1–16. PMC 1218630. PMID 9337844. doi:10.1042/bj3260001.
Siegel RM, Chan FK, Chun HJ, Lenardo MJ. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 2001, 1 (6): 469–74. PMID 11101867. S2CID 345769. doi:10.1038/82712.
Ye S, Goldsmith EJ. Serpins and other covalent protease inhibitors. Curr. Opin. Struct. Biol. 2002, 11 (6): 740–5. PMID 11751056. doi:10.1016/S0959-440X(01)00275-5.
Gupta S. Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp. Gerontol. 2002, 37 (2–3): 293–9. PMID 11772515. S2CID 30243363. doi:10.1016/S0531-5565(01)00195-4.
Pomerantz RJ. Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis. DNA Cell Biol. 2004, 23 (4): 227–38. PMID 15142380. doi:10.1089/104454904773819815.
Zhao LJ, Zhu H. Structure and function of HIV-1 auxiliary regulatory protein Vpr: novel clues to drug design. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2005, 4 (4): 265–75. PMID 15578977. doi:10.2174/1568008043339668.